Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

分组1 - Treace Medical Concepts reported a quarterly loss of $0.25 per share, better than the Zacks Consensus Estimate of a loss of $0.31, and an improvement from a loss of $0.30 per share a year ago, representing an earnings surprise of 19.35% [1] - The company posted revenues of $52.57 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.05%, and an increase from year-ago revenues of $51.11 million [2] - Treace Medical Concepts has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has lost about 3.2% since the beginning of the year, while the S&P 500 has declined by 4.3% [3] - The current consensus EPS estimate for the coming quarter is -$0.27 on revenues of $49.66 million, and for the current fiscal year, it is -$0.86 on revenues of $227.44 million [7] - The Medical - Instruments industry, to which Treace Medical Concepts belongs, is currently in the top 28% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]